A Study of Fycompa (Perampanel) in Korean Participants

CompletedOBSERVATIONAL
Enrollment

3,692

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Epilepsy
Trial Locations (9)

Unknown

Chungju

Wŏnju

Seongnam

Jinju

Gwangju

Busan

Daegu

Daejeon

Seoul

All Listed Sponsors
lead

Eisai Korea Inc.

INDUSTRY

NCT02722590 - A Study of Fycompa (Perampanel) in Korean Participants | Biotech Hunter | Biotech Hunter